gyki 53655 has been researched along with cadmium in 1 studies
Studies (gyki 53655) | Trials (gyki 53655) | Recent Studies (post-2010) (gyki 53655) | Studies (cadmium) | Trials (cadmium) | Recent Studies (post-2010) (cadmium) |
---|---|---|---|---|---|
111 | 0 | 22 | 37,999 | 84 | 18,071 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bureau, I; Mulle, C | 1 |
1 other study(ies) available for gyki 53655 and cadmium
Article | Year |
---|---|
Potentiation of GABAergic synaptic transmission by AMPA receptors in mouse cerebellar stellate cells: changes during development.
Topics: Age Factors; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzodiazepines; Cadmium; Cerebellum; Dose-Response Relationship, Drug; Evoked Potentials; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Kainic Acid; Mice; Neural Inhibition; Neuromuscular Depolarizing Agents; Neurons; Receptors, AMPA; Receptors, Kainic Acid; Synaptic Transmission; Tetrodotoxin | 1998 |